论文信息 - Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model - 字舞流文

Metastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model

P. Pandolfi | T. Giordano | A. Fischer | R. Bronson | D. Dias-Santagata | C. Nucera | J. Kurebayashi | G. Makrigiorgos | V. Nosé | P. Sadow | Jennifer N. Sims | Chen Song | M. Duquette | E. Castellanos-Rizaldos | Michelle Vinco | Amjad Husain | P. Van Hummelen | Z. Antonello